Skip to content

A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01781962
Enrollment
206
Registered
2013-02-01
Start date
2013-01-31
Completion date
2013-06-30
Last updated
2014-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Hypertension, Open-angle Glaucoma

Brief summary

This study will assess angle width in Chinese patients with Open-angle Glaucoma and/or Ocular Hypertension.

Interventions

OTHERNo Treatment

No Treatment was given in this study.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Of Chinese descent * Open-angle Glaucoma or Ocular Hypertension in each eye

Exclusion criteria

* History of a narrow-angle or angle closure glaucoma * Angle abnormalities in either eye

Design outcomes

Primary

MeasureTime frameDescription
Anterior Angle Width Using Anterior Segment Optical Coherence Tomography (AS OCT)Day 1The angle width formed between the eye's cornea and iris in both eyes was measured in microns (µm) using AS OCT, a laser-based, noninvasive, diagnostic system providing high-resolution images of the eye.

Secondary

MeasureTime frameDescription
Number of Study Eyes in Each Shaffer Grade Using Gonioscopic LensDay 1The angle width formed between the cornea and iris in both eyes was measured by gonioscopy using Shaffer grading where: grade 4=wide open, grade 3=moderately open, grade 2=moderately narrow, grade 1=very narrow or grade 0=closed. The number of eyes in each Shaffer Grade is reported.
Number of Study Eyes in Each Step Grade Using Gonioscopic LensDay 1The angle width formed between the cornea and iris in both eyes was measured by gonioscopy using Large Step Grading ranging from 1.0 (smallest angle width) to 7.5 (largest angle width) with 0.5 unit intervals where each Large Step unit represented a fixed length of approximately 200 µm. The number of eyes in each Large Step Grade is reported.

Countries

China

Participant flow

Participants by arm

ArmCount
All Participants
Open-Angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) patients.
206
Total206

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyOther Miscellaneous Reasons5

Baseline characteristics

CharacteristicAll Participants
Age, Customized
45 to 65 years
71 Participants
Age, Customized
<45 years
111 Participants
Age, Customized
>65 years
24 Participants
Sex: Female, Male
Female
91 Participants
Sex: Female, Male
Male
115 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 206
serious
Total, serious adverse events
0 / 206

Outcome results

Primary

Anterior Angle Width Using Anterior Segment Optical Coherence Tomography (AS OCT)

The angle width formed between the eye's cornea and iris in both eyes was measured in microns (µm) using AS OCT, a laser-based, noninvasive, diagnostic system providing high-resolution images of the eye.

Time frame: Day 1

Population: Participants from the Modified Intent-to-treat (mITT) population, all enrolled patients with both gonioscopy and AS OCT measurements, with evaluable data for this outcome measure.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsAnterior Angle Width Using Anterior Segment Optical Coherence Tomography (AS OCT)638.8 µmStandard Deviation 272.67
Secondary

Number of Study Eyes in Each Shaffer Grade Using Gonioscopic Lens

The angle width formed between the cornea and iris in both eyes was measured by gonioscopy using Shaffer grading where: grade 4=wide open, grade 3=moderately open, grade 2=moderately narrow, grade 1=very narrow or grade 0=closed. The number of eyes in each Shaffer Grade is reported.

Time frame: Day 1

Population: Participants from the mITT population, all enrolled patients with both gonioscopy and AS OCT measurements, with data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)Dispersion
All ParticipantsNumber of Study Eyes in Each Shaffer Grade Using Gonioscopic LensGrade 11 eye
All ParticipantsNumber of Study Eyes in Each Shaffer Grade Using Gonioscopic LensGrade 21 eye
All ParticipantsNumber of Study Eyes in Each Shaffer Grade Using Gonioscopic LensGrade 334 eye 334.86
All ParticipantsNumber of Study Eyes in Each Shaffer Grade Using Gonioscopic LensGrade 4369 eye 262.33
Secondary

Number of Study Eyes in Each Step Grade Using Gonioscopic Lens

The angle width formed between the cornea and iris in both eyes was measured by gonioscopy using Large Step Grading ranging from 1.0 (smallest angle width) to 7.5 (largest angle width) with 0.5 unit intervals where each Large Step unit represented a fixed length of approximately 200 µm. The number of eyes in each Large Step Grade is reported.

Time frame: Day 1

Population: Participants from the mITT population, all enrolled patients with both gonioscopy and AS OCT measurements, with data available for this outcome measure.

ArmMeasureGroupValue (NUMBER)Dispersion
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 1.00 eye 126.92
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 1.54 eye 203.66
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 2.036 eye 206.72
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 2.532 eye 212.36
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 3.078 eye 191.87
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 3.524 eye 234.94
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 4.069 eye 290.2
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 4.523 eye 208.44
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 5.034 eye 119.57
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 5.59 eye 221.46
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 6.033 eye 184.16
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 6.528 eye 294.97
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 7.028 eye 158.44
All ParticipantsNumber of Study Eyes in Each Step Grade Using Gonioscopic LensStep Grade 7.57 eye

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026